Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Concomitantly With Routine Pediatric Vaccines in the United Kingdom
Clinical trial NCT03632720 · COMPLETED
Trial details
- NCT number
- NCT03632720
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-10
- Primary completion
- 2022-12-05
- Enrollment
- 788
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.